Added value of anti-Müllerian hormone in prediction of menopause: Results from a large prospective cohort study

Human Reproduction

Volumn 30, Issue 8, 2015, Pages 1974-1981

  Dólleman, Madeleine ^a   Verschuren, W M Monique ^a,b   Eijkemans, Marinus J C ^a   Broekmans, Frank J M ^a   Van Der Schouw, Yvonne T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

anti M llerian hormone; epidemiology; menopause; prediction

Indexed keywords

MUELLERIAN INHIBITING FACTOR; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; FEMALE; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; ORAL CONTRACEPTIVE USE; PREDICTIVE VALUE; PREMENOPAUSE; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; BLOOD; MIDDLE AGED;

ADULT; ANTI-MULLERIAN HORMONE; COHORT STUDIES; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84939607589     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev145     Document Type: Article

References (28)

1. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
2. Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab 2007;18:58-65.
3. Broer SL, Eijkemans MJ, Scheffer GJ, van Rooij I, de Vet A, Themmen AP, Laven JS, de Jong FH, te Velde ER, Fauser BC et al. Anti-Mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2011a;96:2532-2539.
4. Broer SL, Eijkemans MJ, Scheffer GJ, van Rooij IA, de VA, Themmen AP, Laven JS, de Jong FH, te Velde ER, Fauser BC et al. Anti-Mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab 2011b;96:2532-2539.
5. Chambless LE, Diao G. Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med 2006;25:3474-3486.
6. de Graaff AA, Land JA, Kessels AG, Evers JL. Demographic age shift toward later conception results in an increased age in the subfertile population and an increased demand for medical care. Fertil Steril 2011;95:61-63.
7. Dolleman M, Faddy MJ, van DJ, van der Schouw YT, Messow CM, Leader B, Peeters PH, McConnachie A, Nelson SM, Broekmans FJ. The relationship between anti-Mullerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. J Clin Endocrinol Metab 2013a;98:1446-1453.
8. Dolleman M, Verschuren WM, Eijkemans MJ, Dolle ME, Jansen EH, Broekmans FJ, van der Schouw YT. Reproductive and lifestyle determinants of anti-Mullerian hormone in a large population-based study. J Clin Endocrinol Metab 2013b;98:2106-2115.
9. Dossus L, Kvaskoff M, Bijon A, Fervers B, Boutron-Ruault MC, Mesrine S, Clavel-Chapelon F. Determinants of age at menarche and time to menstrual cycle regularity in the French E3N cohort. Ann Epidemiol 2012;22:723-730.
10. Fleming R, Nelson SM. Reproducibility of AMH. Hum Reprod 2012;27:3639-3641.
11. Freeman EW, Sammel MD, Lin H, Gracia CR. Anti-Mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012;97:1673-1680.
12. Gold EB. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am 2011;38:425-440.
13. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP. Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003;211:85-90.
14. Kinney A, Kline J, Kelly A, Reuss ML, Levin B. Smoking, alcohol and caffeine in relation to ovarian age during the reproductive years. Hum Reprod 2007;22:1175-1185.
15. La Marca A, Sighinolfi G, Papaleo E, Cagnacci A, Volpe A, Faddy MJ. Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. PLoS One 2013;8:e57005.
16. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571-576.
17. Morris DH, Jones ME, Schoemaker MJ, McFadden E, Ashworth A, Swerdlow AJ. Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study. Am J Epidemiol 2012;175:998-1005.
18. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
19. Pickering JW, Endre ZH. New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol 2012;7:1355-1364.
20. Rustamov O, Smith A, Roberts SA, Yates AP, Fitzgerald C, Krishnan M, Nardo LG, Pemberton PW. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Hum Reprod 2012;10:3085-3091.
21. Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. Hum Reprod 2011;26:655-661.
22. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141-154.
23. Tehrani FR, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum antimullerian hormone concentration. Menopause 2011;18:766-770.
24. Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab 2013;98:729-735.
25. van Asselt KM, Kok HS, van der Schouw YT, Grobbee DE, te Velde ER, Pearson PL, Peeters PH. Current smoking at menopause rather than duration determines the onset of natural menopause. Epidemiology 2004;15:634-639.
26. van Disseldorp J, Faddy MJ, Themmen AP, de Jong FH, Peeters PH, van der Schouw YT, Broekmans FJ. Relationship of serum antimullerian hormone concentration to age at menopause. J Clin Endocrinol Metab 2008;93:2129-2134.
27. van Rooij I, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-3071.
28. Verschuren WM, Blokstra A, Picavet HS, Smit HA. Cohort profile: the Doetinchem Cohort Study. Int J Epidemiol 2008;37:1236-1241.